UPDATE 1-FDA staff says Acadia's drug for Parkinson's disease psychosis is effective

March 25 (Reuters) - U.S. Food and Drug Administration staff

members said on Friday Acadia Pharmaceuticals Inc's

drug to treat psychosis associated with Parkinson's disease was

an effective...

Read more